EC-70124

N/A

Report date: 2024/11/29 14:02:41

NME

Base Information

Drug NameEC-70124

Drug Alias NameEC-70124

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsSignal transducer and activator of transcription 3 inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors +[8]

TargetsSerine/threonine-protein kinase mTORNuclear factor NF-kappa-B complexSignal transducer and activator of transcription 3 +[8]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesENTRECHEM SL

China Registration ClassN/A

Develop Information

Active CompaniesENTRECHEM SL

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A